Year |
Citation |
Score |
2019 |
Rafie C, Cruz K, Woolman S, Armstrong T, Jaffee E, Torres ER. Abstract 2352: Epigenetic modulation— unlocking the potential of checkpoint inhibition in advanced breast cancer Cancer Research. 79: 2352-2352. DOI: 10.1158/1538-7445.Am2019-2352 |
0.301 |
|
2017 |
Christmas B, Scott B, Armstrong T, Azad N, Jaffee E. Abstract 1686: Epigenetic modulation of the tumor microenvironment enhances vaccine induced T cell responses in a murine model of pancreatic cancer Cancer Research. 77: 1686-1686. DOI: 10.1158/1538-7445.Am2017-1686 |
0.32 |
|
2016 |
Jaffee EM. Abstract IA26: Combinatorial immunotherapies with the potential to reverse the carcinogenesis process Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-Ia26 |
0.328 |
|
2016 |
Jaffee EM. Abstract IA16: Tipping the balance from a procarcinogenic to an antitumor microenvironment in pancreatic cancers Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Ia16 |
0.32 |
|
2015 |
Jaffee EM. Abstract PL04-03: Fatal Attraction: A new story featuring the immune system and pancreatic cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2015-Pl04-03 |
0.316 |
|
2014 |
Patel RK, Ko AH, Onners B, Uram JN, Parkinson R, Sugar E, Lutz E, Zheng L, Laheru DA, Jaffee EM, Le DT. A phase 2, multicenter study of FOLFIRINOX followed by ipilimumab in combination with allogeneic GM-CSF transfected pancreatic tumor vaccine in the treatment of metastatic pancreatic cancer. Journal of Clinical Oncology. 32: TPS4160-TPS4160. DOI: 10.1200/Jco.2014.32.15_Suppl.Tps4160 |
0.309 |
|
2014 |
Jaffee EM. Abstract SY26-01: Vaccine induced immunity against cancer genes to prevent and treat pancreatic cancer Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Sy26-01 |
0.318 |
|
2013 |
Laheru D, Biedrzycki B, Jaffee EM. Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine. Methods in Molecular Biology (Clifton, N.J.). 980: 175-203. PMID 23359154 DOI: 10.1007/978-1-62703-287-2_9 |
0.313 |
|
2013 |
Jaffee E. Abstract CN01-02: Tipping the balance from a procarcinogenic to an anticancer response to prevent pancreatic cancer Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-Cn01-02 |
0.306 |
|
2013 |
Jaffee E. Abstract IA10: Tipping the balance from a procarcinogenic to anticancer response in pancreatic cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-Ia10 |
0.324 |
|
2008 |
Hardiman ER, Jaffee EM. Outreach and peer-delivered mental health services in New York City following September 11, 2001. Psychiatric Rehabilitation Journal. 32: 117-23. PMID 18840566 DOI: 10.2975/32.2.2008.117.123 |
0.448 |
|
2005 |
Laheru D, Biedrzycki B, Thomas AM, Jaffee EM. Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine. Methods in Molecular Medicine. 103: 299-327. PMID 15542914 DOI: 10.1385/1-59259-780-7:299 |
0.312 |
|
2000 |
Jaffee EM. Immunotherapy of cancer. Annals of the New York Academy of Sciences. 886: 67-72. PMID 10667204 DOI: 10.1111/J.1749-6632.1999.Tb09401.X |
0.309 |
|
Show low-probability matches. |